von Hippel–Lindau disease | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

219,315 results for “von Hippel–Lindau disease”

Trials

View all 194555 →

Visualizing Vascular Endothelial Growth Factor (VEGF) Producing Lesions in Von Hippel-Lindau Disease

22 participants · First posted Sep 3, 2009

Data Collection Protocol for Patients With Von Hippel Lindau Disease

125 participants · First posted Jul 20, 2023

Active, not recruiting

Promoting Stress Management and Resilience Among Individuals With Von Hippel- Lindau Disease

40 participants · First posted Feb 21, 2023

Drugs

View all 1778 →

MP-HE-001B

Investigational

Belzutifan(Welireg, 维利瑞)

Conditions: Hemangioblastoma, Pancreatic Neuroendocrine Cancer +1 more

C₁₇H₁₂F₃NO₄S

Von Willebrand factor human(Vonvendi, Wilate)

Conditions: Bleeding, Perioperative Blood Loss

Organizations

View all 254 →

Menarini - Von Heyden GmbH

Germany

Otto-von-Guericke-Universität Magdeburg

Germany

Carl von Ossietzky Universität Oldenburg

Germany

News

View all 22728 →

Belzutifan Shows Sustained Efficacy in VHL-Associated CNS Hemangioblastomas

Arcus's HIF-2α Inhibitor Shows Promise in Kidney Cancer, Despite Gilead's Exit

Pharmaceutical Giants Pfizer, Merck, and AbbVie Lead Innovation Against Global Diseases

Page 1 of 21932